True North Advisors, LLC Bristol Myers Squibb CO Transaction History

True North Advisors, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$68.48 - $81.09 $68 - $81	1 Added 0.0%	21,474 $1.54 Million
Q3 2022 Nov 10, 2022	SELL	$0.13 - $76.84 $26 - $15,905	-207 Reduced 0.95%	21,473 $1.53 Million
Q2 2022 Jul 28, 2022	BUY	$72.62 - $79.98 $6,100 - $6,718	84 Added 0.39%	21,680 $1.67 Million
Q1 2022 May 12, 2022	SELL	$61.48 - $73.72 $172,758 - $207,153	-2,810 Reduced 11.51%	21,596 $1.58 Million
Q4 2021 Feb 11, 2022	BUY	$53.63 - $62.52 $1,716 - $2,000	32 Added 0.13%	24,406 $1.52 Million
Q3 2021 Jun 07, 2022	BUY	$59.17 - $69.31 $253,129 - $296,508	4,278 Added 21.29%	24,374 $1.44 Million
Q2 2021 Jun 07, 2022	BUY	$61.91 - $67.42 $4,333 - $4,719	70 Added 0.35%	20,096 $1.34 Million
Q1 2021 Jun 07, 2022	SELL	$59.34 - $66.74 $21,540 - $24,226	-363 Reduced 1.78%	20,026 $1.26 Million
Q4 2020 May 20, 2022	BUY	$57.74 - $65.43 $57,740 - $65,430	1,000 Added 5.16%	20,389 $1.26 Million
Q3 2020 May 20, 2022	SELL	$57.43 - $63.64 $15,046 - $16,673	-262 Reduced 1.33%	19,389 $1.17 Million
Q2 2020 May 20, 2022	BUY	$54.82 - $64.09 $1.08 Million - $1.26 Million	19,651 New	19,651 $1.16 Million

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of True North Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on True North Advisors, LLC with notifications on news.